Glaukos and Avedro Announce Definitive Acquisition Agreement
Adds Novel Bio-Activated Pharmaceuticals to Glaukos’ New Corneal Health Franchise Potential Revenue Synergies from Complementary Product Portfolios that Leverage Glaukos’…
Pharmaceuticals, Biotechnology and Life Sciences
Adds Novel Bio-Activated Pharmaceuticals to Glaukos’ New Corneal Health Franchise Potential Revenue Synergies from Complementary Product Portfolios that Leverage Glaukos’…
– QBREXZA™ (glycopyrronium) cloth net product sales of $8.1M, more than triple first quarter 2019 sales – End-of-Phase 2 FDA…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative…
Conference Call and Webcast Today, August 7th, at 5:00 p.m. ET DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical…
Conference Call and Webcast Scheduled for 5:00 p.m. Eastern Time BRISBANE, Calif.–(BUSINESS WIRE)–Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine…
Commenced U.S. Launch of DEXTENZA® with Broad Reimbursement Status and Differentiated Product Label BEDFORD, Mass.–(BUSINESS WIRE)–$OCUL #OCUTX–Ocular Therapeutix™, Inc. (NASDAQ:…
Barry Mirrer has joined PROMETRIKA’s Leadership Team as Head of Quality Assurance CAMBRIDGE, Mass.–(BUSINESS WIRE)–PROMETRIKA, LLC is proud to welcome…
DUBLIN–(BUSINESS WIRE)–The “Duchenne Muscular Dystrophy Drugs – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. Duchenne…
DUBLIN–(BUSINESS WIRE)–The “Duchenne Muscular Dystrophy Drugs – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. Duchenne…
Despite preferring services from patient organizations over those from pharmaceutical companies, patients want both to work together to provide a…